首页> 美国卫生研究院文献>Current Health Sciences Journal >Simultaneous Analysis of Clopidogrel Bisulfate Acetylsalicylic Acid and Atorvastatin calcium in Tablets by HPLC Method
【2h】

Simultaneous Analysis of Clopidogrel Bisulfate Acetylsalicylic Acid and Atorvastatin calcium in Tablets by HPLC Method

机译:HPLC法同时分析片剂中硫酸氯吡格雷乙酰水杨酸和阿托伐他汀钙

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The concept of multidrug therapy with clopidogrel, acetylsalicylic acid and atorvastatin provides major advances for patients with acute coronary syndromes (ACS) treated invasively and conservatively to reduce the risk of ischemic events and improve survival. Dual antiplatelet therapy (DAPT) with acetylsalicylic acid and clopidogrel is currently the treatment of choice in acute coronary syndromes and prevention of thrombosis after coronary stent implementation. Present paper presents a simple, rapid and precise reversed phase high performance liquid chromatographic method for simultaneous estimation of clopidogrel hydrogen sulfate, acetylsalicylic acid and atorvastatin calcium from tablet dosage form. The cromatographic analysis was carried out using a ThermoFinnigan Chromatograph with UV detection and separation on an HDS Hypersil C18 column. The elution was isocratic with mobile phase consisting in mixture of 0.01M KH₂PO₄ buffer: acetonitrile: methanol. Chemicals were represented by clopidogrel bisulfat, atorvastatin calcium and acetylsalicylic acid standards with high purity. The quality control samples used in the accuracy and precision evaluation were spiked at low, medium and high concentration levels. Preliminary tests were performed to select optimum conditions for simultaneous separation of all three analytes such as mobile phase composition, proportion and pH. A satisfactory separation of all three drugs was achieved with a mobile phase of 0.01 M KH₂PO₄ buffer (pH adjusted to 2.6 with phosphoric acid):acetonitrile:methanol 20:40:40 v/v/v at flow rate of 0.8 ml/min. The proposed method was validated for linearity, precision and accuracy. The validated method can be successfully applied for simultaneous quantification of clopidogrel, acetylsalycilic acid and atorvastatin either in combination or in single dosage form in quality control analysis. The analytical conditions can also be performed for human plasma analysis.
机译:氯吡格雷,乙酰水杨酸和阿托伐他汀的多药治疗概念为经侵入性和保守治疗的急性冠脉综合征(ACS)患者提供了重大进展,以减少缺血性事件的风险并提高生存率。目前,使用乙酰水杨酸和氯吡格雷双重抗血小板治疗(DAPT)是急性冠脉综合征的首选治疗方法,并在实施冠状动脉支架后预防血栓形成。本文提出了一种简单,快速,精确的反相高效液相色谱方法,用于从片剂剂型中同时估算氯吡格雷硫酸氢盐,乙酰水杨酸和阿托伐他汀钙。使用ThermoFinnigan色谱仪在UVS Hypersil C18色谱柱上进行UV检测和分离,进行色谱分析。用0.01M KH 2 PO 3缓冲液:乙腈:甲醇的混合物组成的流动相进行等度洗脱。化学药品以高纯度氯吡格雷硫酸氢盐,阿托伐他汀钙和乙酰水杨酸标准品为代表。在低,中和高浓度下加标用于准确性和精密度评估的质量控制样品。进行了初步测试以选择最佳条件,以同时分离所有三种分析物,例如流动相组成,比例和pH。用0.01M KH 2 PO 3缓冲液(用磷酸将pH调节至2.6):乙腈:甲醇20∶40∶40v / v / v的流动相,流速为0.8ml / min,能令人满意地分离所有三种药物。所提方法的线性,精度和准确性均得到验证。经验证的方法可以成功地同时用于氯吡格雷,乙酰水杨酸和阿托伐他汀的组合定量或单剂形式的质量控制分析。分析条件也可以用于人体血浆分析。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号